Abraham Ceesay insider trades: Rapport Therapeutics (RAPP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Abraham reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | RAPP | ↓ Sell | 2,210 | $29.16 | $64K | Direct | Oct 23, 2026 (2d) |
| Oct 7, 2026 | RAPP | ↓ Sell | 4,522 | $31.68 | $143K | Direct | Oct 8, 2026 (1d) |
| Sep 23, 2026 | RAPP | ↓ Sell | 2,210 | $39.17 | $87K | Direct | Sep 24, 2026 (1d) |
| Aug 25, 2026 | RAPP | ↓ Sell | 18,921 | $49.57 | $938K | Direct | Aug 26, 2026 (1d) |
| Aug 11, 2026 | RAPP | ↓ Sell | 51,499 | $47.25 | $2.4M | Direct | Aug 12, 2026 (1d) |
| Jul 14, 2026 | RAPP | ↓ Sell | 8,210 | $40.00 | $328K | Direct | Jul 15, 2026 (1d) |
| Jun 29, 2026 | RAPP | ↓ Sell | 8,220 | $39.83 | $327K | Direct | Jul 1, 2026 (2d) |
| Feb 18, 2026 | RAPP | ↓ Sell | 5,833 | $29.34 | $171K | Direct | Feb 19, 2026 (1d) |
| Feb 18, 2026 | RAPP | ↓ Sell | 5,083 | $29.36 | $149K | By Dorothy Ceesay Irrevocable Trust | Feb 19, 2026 (1d) |
| Jan 20, 2026 | RAPP | ↓ Sell | 5,833 | $26.12 | $152K | Direct | Jan 22, 2026 (2d) |
| Jan 20, 2026 | RAPP | ↓ Sell | 5,083 | $26.11 | $133K | By Dorothy Ceesay Irrevocable Trust | Jan 22, 2026 (2d) |
| Dec 17, 2025 | RAPP | ↓ Sell | 5,833 | $29.64 | $173K | Direct | Dec 18, 2025 (1d) |
| Dec 17, 2025 | RAPP | ↓ Sell | 5,083 | $29.63 | $151K | By Dorothy Ceesay Irrevocable Trust | Dec 18, 2025 (1d) |
| Nov 17, 2025 | RAPP | ↓ Sell | 5,833 | $25.19 | $147K | Direct | Nov 18, 2025 (1d) |
| Nov 17, 2025 | RAPP | ↓ Sell | 5,083 | $25.20 | $128K | By Dorothy Ceesay Irrevocable Trust | Nov 18, 2025 (1d) |
| Oct 15, 2025 | RAPP | ↓ Sell | 5,833 | $25.81 | $151K | Direct | Oct 16, 2025 (1d) |
| Oct 15, 2025 | RAPP | ↓ Sell | 5,083 | $25.81 | $131K | By Dorothy Ceesay Irrevocable Trust | Oct 16, 2025 (1d) |
| Sep 17, 2025 | RAPP | ↓ Sell | 40,835 | $26.32 | $1.1M | Direct | Sep 19, 2025 (2d) |
| Sep 17, 2025 | RAPP | ↓ Sell | 35,585 | $26.32 | $936K | By Dorothy Ceesay Irrevocable Trust | Sep 19, 2025 (2d) |
| Sep 4, 2025 | PCRX | ↓ Sell10b5-1 | 2,354 | $27.19 | $64K | Direct | Sep 8, 2025 (4d) |
| Sep 8, 2022 | CERE | ↓ Sell | 19,210 | $32.50 | $624K | Direct | Sep 12, 2022 (4d) |
| Aug 22, 2022 | CERE | ↓ Sell | 9,605 | $32.50 | $312K | Direct | Aug 24, 2022 (2d) |
| Aug 15, 2022 | CERE | ↓ Sell | 9,606 | $34.12 | $328K | Direct | Aug 17, 2022 (2d) |
| Aug 8, 2022 | CERE | ↓ Sell | 57,635 | $34.54 | $2.0M | Direct | Aug 9, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RAPP insiders
Open-market trades in the last 12 months
About Abraham Ceesay's insider trades
Abraham Ceesay is Chief Executive Officer at Rapport Therapeutics (RAPP). Since Aug 8, 2022, Abraham has reported no open-market purchases and 24 sales worth $11.1M on SEC Form 4. In the last 12 months: 15 sales ($5.5M).
1 sale (1% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (12 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RAPP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.